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Background: The Corona-Score is one of the first and most widely used predictive model for coronavirus 2 (SARSCoV-2) infection. The purpose of this study was to validate the performance of Corona-Score in a cohort of
Pakistani patients pursuing care for suspected infection.
Methods: After seeking institution’s ethical committee exemption, results of serum lactate dehydrogenase (LDH),
C-reactive protein (CRP), ferritin, absolute lymphocyte and neutrophil counts, chest x-ray findings and de
mographics of suspected COVID-19 cases with respiratory symptoms were recouped from electronic medical
record. The pre-validated score as proposed by Kurstjens S et al., was calculated. The subjects were divided into
SARS-CoV-2 positive and negative on the basis of reverse transcription-polymerase chain reaction (RT-PCR)
findings. Median and interquartile range (IQR) was calculated for the score in the two groups and the difference
was assessed using the independent sample median test. Receiver operating characteristics (ROC) curve analysis
was plotted. Statistical analyses were carried out using SPSS 26, with statistical significance set at p value < 0.05.
Results: A total of sixty cases, 30 (50%) RT-PCR positive and 30 (50%) negative with a median Corona-Score of
3.5 (IQR: 0–6) and 1.5 (IQR: 0–4) respectively, were evaluated. A p-value of 0.61 showing no statistically sig
nificant between group differences was observed. The area under the curve of Corona-Score in our population of
patients was 0.59 (95% CI: 0.45–0.74). Using the cut-off values of four originally identified by Kurstjens et al. the
model displayed 43.3% sensitivity and 70% specificity with an overall accuracy of 56.67%.
Conclusion: Corona-Score displayed a lower diagnostic accuracy which may be attributable to the different ge
netic framework, viral strain and severity of the disease in Pakistanis compared to the population where this
score was originally validated. However, large multi-center studies across the country are dire need of time to
evaluate the score in overly exhausted health care setup and limited availability of PCR testing.

1. Introduction
The novel Coronavirus disease 2019 (COVID-19), caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), after its origin
in China in 2019, became a global pandemic in 2020 [1]. The disease
can present as mild, flu-like illness, to critical condition requiring
intensive care admission and mechanical ventilation [2,3]. The diag
nosis of COVID-19 is still clearly based on detection of SARS-CoV-2 RNA
in upper or lower respiratory tract specimens via nucleic acid amplifi
cation tests (NAATs) [4]. However, these techniques have a few crucial
disadvantages, such as the relatively low diagnostic sensitivity in
nasopharyngeal swabs, shortage of testing materials and personnel, as

well as time consuming, which constitute issues for purposes of huge
populace screening [5].
Clinical laboratories have provided a significant contribution to
wards diagnosis of COVID-19. To accelerate the diagnostic process, a
point-based algorithm, the Corona-Score, was developed [6]. It is one of
the first and most widely used predictive model that includes age,
gender, chest X-ray and five laboratory investigations: lactate dehy
drogenase (LDH), C-reactive protein (CRP), ferritin, and neutrophil and
lymphocyte counts. This algorithm has the ability to predict whether a
patient presenting with respiratory symptoms is probable to have
COVID-19. A current study utilizing the Corona-Score in The
Netherlands showed 91% accuracy, 96% sensitivity, and 95% specificity

* Corresponding author. Section Head Chemical Pathology Department of Pathology and Laboratory Medicine, The Aga Khan University, Pakistan.
E-mail addresses: sibtain.ahmed@aku.edu (S. Ahmed), umer.naeem@aku.edu (M.U. Naeem Effendi), zeeshan.ansar@aku.edu (Z.A. Ahmed), imran.siddiqui@aku.
edu (I. Siddiqui), lena.jafri@aku.edu (L. Jafri).
https://doi.org/10.1016/j.amsu.2021.102537
Received 10 May 2021; Received in revised form 29 June 2021; Accepted 1 July 2021
Available online 2 July 2021
2049-0801/© 2021 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
(http://creativecommons.org/licenses/by/4.0/).

This is an open access article under the CC BY license

S. Ahmed et al.

Annals of Medicine and Surgery 67 (2021) 102537

for differentiating patients testing positive or negative for SARS-CoV-2
by NAAT [6]. In fear of a shortage of testing capacity, embracing this
algorithm could diminish the number of patients for whom RT-PCR
testing is required. Moreover, in already resource constrained health
care set ups with limited testing capacities in majority of the Indo-Pak
sub-continent can facilitate rapid decision making in triage.
Although these data are inspiring, the model needs to be validated in
other clinical and healthcare settings. Therefore, the purpose of this
study was to evaluate the performance of Corona-Score in a cohort of
Pakistani patients pursuing care for suspected COVID-19 infection.

PCR positive group and 1.5 (IQR: 0–4) in the group that tested negative.
The Corona-Score value was found to be elevated in participants with
SARS-CoV-2 infection compared to those without. However, no statis
tically significant between group differences was observed on
independent-samples median test with a p-value of 0.605 as shown in
Fig. 1.
The area under the curve of Corona-Score in our population of pa
tients was 0.59 (95% CI: 0.45–0.74). Using the cut-off values of 4 orig
inally identified by Kurstjens et al. for their study population, the model
displayed 43.3% sensitivity and 70% specificity with an overall accuracy
of 56.67%. The results of ROC curve analysis is shown in Fig. 2.

2. Material and methods

4. Discussion

The study was conducted at the Section of Chemical Pathology in
collaboration with the Section of Molecular Pathology, Department of
Pathology and Laboratory Medicine, Aga Khan University (AKU), Kar
achi, Pakistan, from August 2020 to January 2021. Permission form
AKU’s Ethical Review committee was sought. The subjects were divided
into SARS-CoV-2 positive and negative on the basis of reverse
transcription-polymerase chain reaction (RT-PCR) results on a standardof-care nasopharyngeal swab.
Retrospective biochemical, hematological and imaging data was
retrieved from the Integrated Laboratory Management System (ILMS).
Biochemical parameters retrieved included serum LDH, CRP and
ferritin. Hematological parameters recovered included absolute
neutrophil and lymphocyte count. Presence of infiltrates on chest X-ray
was the only radiological parameter included. The laboratory services at
AKU operates according to the highest degree of quality and are
accredited by Joint Commission International (JCIA) and College of
American Pathologists (CAP).
The pre-validated score as proposed by Kurstjens S et al. was calcu
lated using Microsoft Excel for windows [6]. According to the
Corona-Score instructions, concentrations of ferritin were multiplied by
a harmonization factor of 1.2 for Siemens equipment. Based on age,
gender, biochemical and radiological data scores were assigned to each
parameter according to a pre-defined criteria as outlined by Kurstjens
et al. [6]. The Corona-Score is obtained by the summation of the score
for each parameter. The final score is calculated from a minimum of 0 to
a maximum of 14 points.
Median and interquartile range (IQR) was calculated for the score in
the two groups and the difference was assessed using the independent
sample median test. Receiver operating characteristics (ROC) curve
analysis was plotted. Statistical analyses were carried out using Statis
tical Package for the Social Sciences (SPSS) version 26, with statistical
significance set at p < 0.05. The study was exempted by the institutional
ethical review committee of the AKU, Karachi (ERC#2020-5168-14099)
with waiver of informed consent. The study was also registered with
Chinese Clinical Trial Registry (Registration No: ChiCTR2100042375).
Furthermore, this work has been reported in line with the STROCSS
criteria [7].

Thinking about the susceptible public health and healthcare system
of Pakistan, and abrupt rise in number of infected cases, the country
certainly has high possibility of morbidity and mortality associated with
COVID-19. A number of interlaced reasons that put the Pakistani pop
ulation at increased risk can be categorized into public reluctance
(poverty, illiteracy, carelessness, rural lifestyle), healthcare personnel
associated demurrals (reduced caregiver to patient ratio, inadequate
knowledge and training of healthcare professionals, meager collabora
tion) and ineffective organizations and authorities (unstable healthcare
infrastructure, lack of infection control strategies, poor scrutiny system
and resource constraints) [8]. Another issue is the restricted capacity of
laboratories and it seems difficult to expand the laboratory facilities for
large scale testing [9,10].
Population-scale testing for COVID-19 is probably the most ideal
approach to restrict mortality rates. Large scale testing identifies and
isolates infections quickly, restricting the virus’ spread and shielding
susceptible populations [11]. The diagnosis of COVID-19 relies on
detection of SARS-CoV-2 RNA in upper or lower respiratory tract spec
imens via RT-PCR [12]. However, RT-PCR is time consuming and scar
city of testing materials and facility enforce a grave hazard [13]. The
Corona-Score, a point-based algorithm, incorporates routinely con
ducted blood tests that are widely available and performed on auto
mated platforms with very swift turn-around time [6]. The Corona-Score
helps predict the likelihood of SARS-CoV-2 infection, and utilizing this
score accelerates determination of isolation needs and also reduces

3. Results
A total of 60 cases i.e. 30 (50%) positive and 30 (50%) negative by a
nasopharyngeal swab RT-PCR testing were evaluated. The distribution
of gender amongst RT-PCR positive and negative groups are shown in
Table 1.The median Corona-Score of 3.5 (IQR: 0–6) was found in the RTTable 1
Details of study subjects and median Corona-Score.
Male (n)
Female (n)
Corona-Score (Median IQR)
Age (years)

RT-PCR Positive

RT-PCR Negative

12
18
3.5 (0–6)
33.1±6.5

13
17
1.5 (0–4)
60.5±16.5

Fig. 1. Independent sample median test for corona-score between groups pvalue 0.605.
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5. Conclusion
Corona-Score displayed a lower diagnostic accuracy which may be
attributable to the different genetic framework, viral strain and severity
of the disease in Pakistanis compared to the population where this score
was originally validated. Corona Score is an easy-to-use algorithm for
identification of Covid-19 patients with respiratory symptoms and needs
to be further validated on a bigger sample size. Large multi-center
studies across the country are dire need of time to evaluate the score
in overly exhausted health care setup and limited availability of PCR
testing.
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Fig. 2. Receiver operating characteristics (ROC) curve analysis of the CoronaScore against COVID-19 PCR

RT-PCR testing. It also eliminates the expertise and training of a person
required to obtain a right, representative sample. Moreover, the PCR test
can itself suffer from low diagnostic yield particularly false negatives in
presence of classic sign and symptoms due to discrepancy in sample
collection practices and timeline of infectivity, this is where corona
score can produce vital information and necessitates protective mea
sures for a likely true positive case.
In this study the Corona Score exhibited an AUC of 0.59, which was
considerably lower compared to the scores evaluation in Dutch and
United States health care set ups [5,6]. The score was developed by
Kurstjens S et al in a set of 967 Dutch patients seeking emergency
care at multiple centers in Netherlands, using artificial intelligence
based computational sampling, followed by validation of the
model in 592 patients. The external validation by Lippi G et al in
the United States of America, had also reported a lower AUC (0.74)
and sensitivity (82%), but slightly higher specificity (96%)
compared to the original Dutch cohort [5,6]. The authors have
linked the variation to the populations’ specific differences, loca
tion specific viral strains and the variance of health care structure
and care provision between the three different health settings from
Europe, United States and Asia.
Findings of our study were reported from a single institute with
a relatively small sample size which could be the limitations of our
study and there exists a likelihood that significant improvement in
diagnostic accuracy and predictive performance may arise with
larger sample size. Secondly, as it was a retrospective analysis,
differences in underlying patient co-morbidities could not be
evaluated which may also contribute to these observation. Keeping
in view the resource constraints and additional biochemical pa
rameters, the score is unlikely to replace molecular analysis, but it
can provide a practical supplement for assessing pre- and post-test
probabilities and can serve as a screening tool for the control
groups in COVID-19 clinical studies as suggested by Lippi G et al
[5]. Moreover, we also propose to investigate the prognostic utility of
corona score in a representative cohort to assist optimal intensive
resource allocation and attain patient centered outcomes.
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